QC
MRVI icon

Quent Capital’s Maravai LifeSciences MRVI Stock Holding History

Quent Capital’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$84.9K Hold
30,000
– – 0.01% 595
2025
Q4 		$97.5K Buy
30,000
+29,960
+74,900% +$101K 0.01% 568
2025
Q3 		$115 Buy
+40
New +$102 ﹤0.01% 1407
2025
Q2 		– Sell
-47
Closed -$104 – 879
2025
Q1 		$104 Hold
47
– – ﹤0.01% 1301
2024
Q4 		$256 Sell
47
-15,170
-100% -$97.6K ﹤0.01% 1295
2024
Q3 		$126K Hold
15,217
– – 0.01% 436
2024
Q2 		$109K Buy
15,217
+160
+1% +$1.38K 0.01% 436
2024
Q1 		$131K Buy
15,057
+15,000
+26,316% +$101K 0.02% 422
2023
Q4 		$373 Sell
57
-401
-88% -$2.59K ﹤0.01% 1300
2023
Q3 		$4.58K Hold
458
– – ﹤0.01% 1072
2023
Q2 		$5.69K Sell
458
-18
-4% -$243 ﹤0.01% 1038
2023
Q1 		$6.67K Hold
476
– – ﹤0.01% 994
2022
Q4 		$6.81K Buy
476
+331
+228% +$5.21K ﹤0.01% 964
2022
Q3 		$4K Hold
145
– – ﹤0.01% 1011
2022
Q2 		$4K Hold
145
– – ﹤0.01% 984
2022
Q1 		$5K Buy
145
+17
+13% +$570 ﹤0.01% 1050
2021
Q4 		$5K Buy
+128
New +$5.18K ﹤0.01% 920

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Quent Capital's MRVI Position: Q1 2026 in Review

Quent Capital held its Maravai LifeSciences (MRVI) position steady in Q1 2026 at 30,000 shares worth $84.9K. The position accounts for 0.01% of the portfolio, ranked #595.

Quent Capital first reported a position in MRVI in Q4 2021 and has held it in 17 quarters since. The position peaked at $131K in Q1 2024. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Quent Capital held 30,000 shares of Maravai LifeSciences worth $84.9K as of Q1 2026.
  • Quent Capital left its Maravai LifeSciences share count unchanged in Q1 2026.
  • Maravai LifeSciences made up 0.01% of Quent Capital's portfolio in Q1 2026, its #595 holding.
  • Quent Capital first reported a position in Maravai LifeSciences in Q4 2021 and has held it in 17 quarters since.
  • Quent Capital's Maravai LifeSciences position peaked at $131K in Q1 2024.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.